SPRB vs STE · rev $4.9M vs P/E 25, rev $5.46B
Spruce Biosciences Inc (SPRB) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
SPRB currently screens at market cap $3.0M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the SPRB and STE stock pages for the full models.
Not investment advice.